Cyclone Montha crossed the Andhra Pradesh coast, resulting in two deaths, extensive crop damage, and disruptions to power and transportation. Neighboring Telangana also experienced heavy rains. Government relief efforts are underway.
Tamil Thalaivas registered their eighth win of the season with a convincing 42-32 win over Bengaluru Bulls in the Pro Kabbadi League in Pune on Sunday.
Moein Shafaghi and Himanshu dished out superb performances as Tamil Thalaivas thrashed Bengal Warriorz 60-29 in their Pro Kabaddi League match in Pune on Wednesday.
For the Thalaivas, a Super Tackle sent Arjun to the bench but the impressive start by the defenders did not last for too long.
Olympic medallist Saina Nehwal caught with Rajasthan Royals' players and support staff.
Sebi will e-auction next month, 48 jewellery and ornaments of gold (3.21 kg) of Sai Prasad group
On Friday morning, the Mumbai crime branch is carrying out raids at premises of former Mumbai Congress chief Kripashankar Singh including his Bandra residence. The raids come after a first information report was recently filed against the Congress leader for amassing disproportionate assets worth crores.
The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.
Mumbai police on Thursday issued licence to two dance bars as the per the new guidelines laid down by the Maharashtra government.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.
The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.
Sebi had directed some of these companies to wind up their unregistered schemes and repay investors.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances